Discovery & Development US 2026
Hilton San Diego Bayfront, CA
.png?width=500&height=200&name=Neuroscience%20US%202026%20(Light).png "Neuroscience US 2026 (Light)")
The Power Of Partnerships: Aligning Pharma, Biotech, And Academia To Accelerate Development & Innovation
Panel Discussion• Bridging cultures and goals
• Shared resources and expertise
• Accelerating translation
• How partnerships can streamline moving discoveries from the lab to clinical development and market
Novel Neuro-Immunological Targets
Industry PresentationCNS Drug Discovery Case Study
Industry PresentationDevelopment Of Small Molecule Huntington’s Disease Therapeutics With A Novel Mechanism Of Action
Industry Presentation• Hit identification in a phenotypic screen
• Demonstration of selective degradation of mutant huntingtin and cellular disease phenotype reversal
• PK/PD relationship in preclinical mouse models
Development Of Novel Therapeutic Drugs For Neurodegenerative Diseases
Industry PresentationSmall Molecules To Mitigate Cisplatin Toxicities Including Hearing Loss
Industry PresentationDelivering Therapies Across The Blood-Brain Barrier
Panel Discussion• Developing optimized BBB models for drug discovery
• Predicting future
• Recent technological advancements & platforms
• Challenges and unities for the delivery of biopharmaceuticals
• Using nasal to brain route
Targeted, Long-Term Durability & Release
Industry PresentationReinventing CNS Drug Discovery With AI And Human Brain Organoids
Industry PresentationUnderstanding The Role Of AI & Data In Neuroscience Research
Industry PresentationGenomics Technologies For Neurological Indications
Industry PresentationTransformative Gene Therapies For Treating Rare Diseases Using A Novel Plant-Based Manufacturing
Industry PresentationWhere Smart Capital Meets Science: Investing In The Next Wave Of Drug Discovery Innovation
Panel Discussion• How investors evaluate emerging drug discovery technologies
o AI in drug discovery
• What drives funding decisions in a shifting biotech market
• Where capital is flowing next
• How investor are looking at non-dilutive founding
Beyond The Hype: AI, Data & The Industry Shift In Drug Discovery R&D
Panel Discussion• How industry dynamics are reshaping pharma R&D strategy & decision-making
• Digital transformation, AI & data-driven labs of the future
• What leaders need to prioritize to turn innovation into real scientific & business impact
Women In Drug Discovery & Development
Panel Discussion• Exploring pathways to leadership, career progression, and influence for women across drug discovery and development organizations
• Addressing barriers to advancement while sharing strategies to foster mentorship, sponsorship, and greater diversity in scientific innovation and decision-making
Innovation to Impact: Market Strategies Driving the Next Wave of Drug Delivery Technologies
Panel Discussion• What actually defines a “successful” delivery innovation in the market?
• From lab breakthrough to commercial product: where do most strategies fail?
• Pharma vs biotech vs academia: who owns the pathway to market?
• Market access and reimbursement as the real gatekeepers of innovation
New Data Tools For Taking Biomarkers To Clinical Trials
Industry PresentationPartnerships, Platforms Or Acquisitions: What Is The Winning Model For Brain Health Innovation?
Panel Discussioncollaboration models that actually work
• When to partner vs acquire vs build internally
• Data-sharing in a competitive landscape
• Public-private partnerships in USA: success stories & failures
Bridging The Translational Gap In Neurodegenerative Drug Development
Panel Discussion• Building more predictive preclinical programs using human-relevant models and biomarkers
• Leveraging AI to improve target prioritization, patient stratification, and clinical trial design
• Overcoming the biggest barriers to translating promising discoveries into clinical success
• What recent neuroscience programs have taught us about reducing late-stage attrition
Single-Cell And Spatial Omics Approaches For Functional Genomics In Neuroscience
Industry PresentationDealing With High Manufacturing And Product Costs In The Gene Therapy Space
Roundtable DiscussionFrom Oral to Inhaled: Lifecycle Delivery Strategies for Pulmonary Disease Therapeutics
Roundtable DiscussionWhen and why to consider alternative delivery routes as lifecycle extensions for oral drugs
Practical formulation, device, and regulatory considerations when repurposing a candidate for inhalation
Lessons learned and open questions across industry and academia
AI Rewiring The Future Of Drug Discovery
Industry Presentation• Taking a deep dive into generative AI for molecular design to illustrate individual methods that have transformative implications
• Putting it all together – active learning and multi-property optimisation for multiple drug properties
• Using AI to integrate early and late-stage considerations – agentic AI approaches
• How do we collaborate across the industry to develop these frameworks?
AI & In Silico Tools In Formulation Development
Roundtable DiscussionChallanges Of Adopting NAMs: Regulatory & Technical Bottlenecks
Roundtable Discussion• Navigating regulatory uncertainty, validation standards, and industry confidence when integrating NAMs into development pipelines
• Overcoming technical hurdles including model reproducibility, data translation, scalability, and cross-platform comparability
Programming Skeletal Muscle As A Bioreactor – Building The Next Generation Of DNA-Encoded Medicines
Roundtable Discussion- Explore the potential of skeletal muscle as a programmable in vivo bioreactor for sustained therapeutic protein production
- Contrast non-viral DNA-based delivery with AAV gene therapy, including differences in payload flexibility, manufacturability, immune barriers, and repeat-dosing potential
- Discuss the therapeutic areas where durable, tunable protein expression could reshape the future of biologics, from rare diseases to chronic conditions and infectious disease countermeasures
The Use Of Quantum Mechanics In The Future Of Drug Discovery
Roundtable Discussion• Implementing AI to aid in generative design
• Looking to the future
Solution Provider Presentation
Solution Provider PresentationCritical Attributes For Successful mRNA Based Drug Products
Roundtable Discussion• What are critical elements for drug substance?
• What makes a good delivery system?
• How sustainable can mRNA-based drug products be?
Afternoon Break & Refreshments
Lunch Break
Morning Break & Refreshments
Close of Day One & Networking Drinks Reception
Lunch Break
End of Event
Morning Break & Refreshments
Regulatory Acceptance Of Human On A Chip Systems For Neurological Diseases And Conditions
Industry PresentationNo sessions found matching your filters.